Oliver Gautschi

Luzern, LU, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 26, 2026

Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140.

Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life.

Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Journal: Oncology

Published: November 27, 2025

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 17, 2025

Psychosocial Support Needs and Utilization of Support Among Survivors of Cancer in Young Adulthood in Switzerland: A Report From the Adolescent and Young Adult (AYA) Psychosocial Health Study.

Psychosocial Support Needs and Utilization of Support Among Survivors of Cancer in Young Adulthood in Switzerland: A Report From the Adolescent and Young Adult (AYA) Psychosocial Health Study.

Journal: Psycho-oncology

Published: July 11, 2025

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 15, 2025

Effectiveness of a Nurse-Led Patient Education for Oncology Patients to Promote Self-Management in Pain Therapy - An Exploratory Before-After Study.

Effectiveness of a Nurse-Led Patient Education for Oncology Patients to Promote Self-Management in Pain Therapy - An Exploratory Before-After Study.

Journal: Pain management nursing : official journal of the American Society of Pain Management Nurses

Published: March 30, 2025

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 21, 2025

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.

Journal: ESMO open

Published: January 27, 2024

Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.

Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 01, 2023

Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.

Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.

Journal: PharmacoEconomics

Published: July 18, 2023

Showing 1-12 of 100

Last Updated: 09/26/2026